Ali Amini Harandi

1.2k total citations
49 papers, 795 citations indexed

About

Ali Amini Harandi is a scholar working on Pulmonary and Respiratory Medicine, Plant Science and Physiology. According to data from OpenAlex, Ali Amini Harandi has authored 49 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Plant Science and 9 papers in Physiology. Recurrent topics in Ali Amini Harandi's work include Pesticide Exposure and Toxicity (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (5 papers). Ali Amini Harandi is often cited by papers focused on Pesticide Exposure and Toxicity (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (5 papers). Ali Amini Harandi collaborates with scholars based in Iran, United States and Italy. Ali Amini Harandi's co-authors include Mostafa Ghanei, Zohreh Poursaleh, Jafar Aslani, Majid Shohrati, Shahrzad Shahidi, Masood Mohseni, Marco Chilosi, Moslem Bahadori, Hassan Akbari and Henry D. Tazelaar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Ali Amini Harandi

46 papers receiving 769 citations

Peers

Countries citing papers authored by Ali Amini Harandi

Since Specialization

Citations

This map shows the geographic impact of Ali Amini Harandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Amini Harandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Amini Harandi more than expected).

Fields of papers citing papers by Ali Amini Harandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Amini Harandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Amini Harandi. The network helps show where Ali Amini Harandi may publish in the future.

Co-authorship network of co-authors of Ali Amini Harandi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Amini Harandi. A scholar is included among the top collaborators of Ali Amini Harandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Amini Harandi. Ali Amini Harandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study 2023 ·Medicine ·Hossein Pakdaman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ali Amini Harandi	3
2	Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study 2018 ·Dementia and Geriatric Cognitive Disorders Extra ·Hossein Pakdaman, (unknown), Mehdi Abbasi, (unknown), (unknown), Farzad Ashrafi, (unknown), Ali Amini Harandi	4
3	MLC601 in vascular dementia: an efficacy and safety pilot study 2017 ·Neuropsychiatric Disease and Treatment ·Hossein Pakdaman, Ali Amini Harandi, (unknown), Mehdi Abbasi, Majid Ghaffarpour, Farzad Ashrafi, (unknown), (unknown)	4
4	Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study 2017 ·Dementia and Geriatric Cognitive Disorders Extra ·(unknown), Ali Amini Harandi, Mehdi Abbasi, (unknown), Farzad Ashrafi, (unknown), Farhad Assarzadegan, Behdad Behnam, Mehran Arab Ahmadi	7
5	Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran 2016 ·Neurological Sciences ·Hossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, (unknown), (unknown), (unknown), (unknown), Omidvar Rezaei, (unknown), Guive Sharifi, (unknown), (unknown), Farzad Ashrafi, (unknown), (unknown), Mehran Arab Ahmadi, Behdad Behnam	20
6	Frequency distribution of gastro esophageal reflux disease in inhalation injury: A historical cohort study 2015 ·Journal of Research in Medical Sciences ·Rasoul Aliannejad, (unknown), Mostafa Ghanei, (unknown), Farshid Alaeddini, Ali Amini Harandi	4
7	Efficacy of Tiotropium Bromide and Rehabilitation Treatment on Pulmonary Function of Patients With Sulfur Mustard Lung Injury 2015 ·Iranian Red Crescent Medical Journal ·Majid Shohrati, (unknown), (unknown), (unknown), Ali Qazvini, (unknown), Ali Amini Harandi, Mostafa Ghanei	2
8	Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial 2015 ·SHILAP Revista de lepidopterología ·Hossein Pakdaman, Ali Amini Harandi, (unknown), (unknown), (unknown), (unknown), (unknown), Farzad Ashrafi, (unknown), (unknown), (unknown)	15
9	Barking seizure: Acute episodes of barking in a 75-year-old previously healthy man 2012 ·Seizure ·Ali Amini Harandi, (unknown), Marjan Asadollahi, Farzad Fatehi, Hossein Pakdaman, (unknown)	2
10	Combination therapy for airflow limitation in COPD 2012 ·DARU Journal of Pharmaceutical Sciences ·Mostafa Ghanei, (unknown), Ali Amini Harandi, Farshid Alaeddini, Majid Shohrati, Jafar Aslani	5
11	Chronic pulmonary complications in Iraq-Kurdistan chemical weapons victims 2011 ·Majallah-i ṭibb-i niẓāmī ·Zohreh Poursaleh, (unknown), (unknown), Ali Amini Harandi	0
12	Pathogenesis and treatment of skin lesions caused by sulfur mustard 2011 ·Cutaneous and Ocular Toxicology ·Zohreh Poursaleh, Mostafa Ghanei, Farhang Babamahmoodi, Morteza Izadi, Ali Amini Harandi, (unknown), (unknown), (unknown), (unknown), Seyed Naser Emadi	23
13	The Respiratory Toxicities of Mustard Gas 2010 ·SHILAP Revista de lepidopterología ·Mostafa Ghanei, Ali Amini Harandi	2
14	Long-term pulmonary complications of chemical warfare agent exposure in Iraqi Kurdish civilians 2010 ·Inhalation Toxicology ·Mostafa Ghanei, Mostafa Naderi, (unknown), Ali Amini Harandi, Nicholas S Hopkinson, Zohreh Poursaleh	27
15	Lung Carcinogenicity of Sulfur Mustard 2010 ·Clinical Lung Cancer ·Mostafa Ghanei, Ali Amini Harandi	28
16	Long term cardiac abnormality after single high dose exposure to sulfur mustard? 2009 ·PubMed ·Bahram Pishgoo, Mostafa Ghanei, Ali Amini Harandi, (unknown), (unknown)	7
17	Hypnotherapy in Management of Pain and Reexperiencing of Trauma in Burn Patients 2008 ·International Journal of Clinical and Experimental Hypnosis ·(unknown), Ali Amini Harandi, Ali Gholamrezaei, (unknown), Peyman Salehi	16
18	An International collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients 2008 ·Respiratory Medicine ·Mostafa Ghanei, Henry D. Tazelaar, Marco Chilosi, Ali Amini Harandi, Mohammadreza Peyman, Hassan Akbari, (unknown), Moslem Bahadori, Jafar Aslani, Azam Mohammadi	96
19	Inhaled Corticosteroids and Long-Acting β2-Agonists in Treatment of Patients with Chronic Bronchiolitis Following Exposure to Sulfur Mustard 2007 ·Inhalation Toxicology ·Mostafa Ghanei, Majid Shohrati, Ali Amini Harandi, Mehdi Eshraghi, Jafar Aslani, Farshid Alaeddini, (unknown)	39
20	Sinus CT Scan Findings in Patients with Chronic Cough Following Sulfur Mustard Inhalation: A Case-Control Study 2006 ·Inhalation Toxicology ·Mostafa Ghanei, Ali Amini Harandi, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact